| 摘要 |
PCT No. PCT/EP97/05530 Sec. 371 Date Jun. 11, 1999 Sec. 102(e) Date Jun. 11, 1999 PCT Filed Oct. 8, 1997 PCT Pub. No. WO98/17668 PCT Pub. Date Apr. 30, 1998The invention relates to thienopyrimidine of the formula (I) as well as to their physiologically acceptable salts, wherein R1, R2, R3, R4, X and n have the meaning cited in claim 1. Said compounds exhibit a phosphodiesterase V inhibition and can be used in the treatment of cardiovascular dieases and for the treatment and/or therapy potency disorder. |
